NCT00894010View on ClinicalTrials.gov

Photosensitivity Proof of Concept Trial

PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

May 31, 2009

Primary Completion Date

June 30, 2011

Study Completion Date

June 30, 2011

Conditions
Photosensitive Epilepsy
Interventions
DRUG

carbamazepine 400mg

DRUG

levetiracetam 1000mg

Trial Locations (2)

10016

NYU Comprehensive Epilepsy Center, New York

21287

Johns Hopkins Hospital, Adult Epilepsy Center, Baltimore

Sponsors

Collaborators (1)

GlaxoSmithKline
All Listed Sponsors
collaborator

The Epilepsy Research Foundation

UNKNOWN

collaborator

GlaxoSmithKline

INDUSTRY

lead

The Epilepsy Study Consortium

OTHER